TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 28.80
+1.35 (4.92%)
At close: Jul 9, 2026
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 5.86 billion as of July 9, 2026. Its market cap has increased by 511.18% in one year.
Market Cap
5.86B
Enterprise Value
5.60B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
28.80
Market Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has increased from 3.83B to 5.86B, an increase of 53.20%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.86B | 224.33% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.46B |
| Savior Lifetec | 6.58B |
| TaiGen Biopharmaceuticals Holdings | 6.55B |
| Sinphar Pharmaceutical | 6.43B |
| AnnJi Pharmaceutical | 6.23B |
| Mycenax Biotech | 5.48B |
| Medigen Biotechnology | 5.33B |
| UnicoCell Biomed | 5.18B |